Progesterone receptor loss identifies luminal-type local advanced breast cancer with poor survival in patients who fail to achieve a pathological complete response to neoadjuvant chemotherapy
Sheng Chen(Zhejiang Cancer Hospital), Zhi‐Ming Shao(Fudan University Shanghai Cancer Center)
Cited by 36
Related Papers
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
|Annals of Oncology|2015|1.8k
Effects of dietary intervention on human diseases: molecular mechanisms and therapeutic potential
|Signal Transduction and Targeted Therapy|2024|187
Characterization of PIK3CA and PIK3R1 somatic mutations in Chinese breast cancer patients
|Nature Communications|2018|183
GCH1 induces immunosuppression through metabolic reprogramming and IDO1 upregulation in triple-negative breast cancer
|Journal for ImmunoTherapy of Cancer|2021|55
Integrated analysis reveals the molecular features of fibrosis in triple-negative breast cancer
|Molecular Therapy — Oncolytics|2022|40